Pharmaceuticals by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Viatris has the lowest figure of the 39 pharmaceuticals ranked by P/B ratio, at 1.7, followed by BioMarin Pharmaceutical (1.8) and Pfizer (1.8). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
39
Lowest
Viatris1.7
Median
6.8
Combined market value
$5.17T
Countries
10
Not ranked
22no P/B ratio on file

Market values as of .

Pharmaceuticals by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ViatrisVTRS · Health Care1.7$23.7B$20.63 0.53% down 94% up United States
2BioMarin PharmaceuticalBMRN · Health Care1.8$11.3B$58.39 0.69% up 7% up United States
3PfizerPFE · Health Care1.8$162.7B$28.54 1.11% down 13% up United States
4Elanco Animal HealthELAN · Health Care2.0$13B$26.06 1.33% down 23% up United States
5Legend BiotechLEGN · Health Care2.5$3.2B$16.27 1.75% up 46% down United States
6Edgewise TherapeuticsEWTX · Health Care2.8$4.6B$42.05 3.73% down 97% up United States
7Regeneron PharmaceuticalsREGN · Health Care2.9$99.5B$961.54 0.96% up 31% up United States
8Abbott LaboratoriesABT · Health Care3.6$184B$106.24 1.13% down 17% down United States
9United TherapeuticsUTHR · Health Care3.9$24.7B$579.15 1.48% down 23% up United States
10Dianthus TherapeuticsDNTH · Health Care4.0$4.9B$87.28 2.54% down 119% up United States
11Definium TherapeuticsDFTX · Health Care4.2$4B$29.36 2.64% down 164% up United States
12Royalty PharmaRPRX · Health Care4.5$39.3B$68.35 0.26% down 74% up United States
13Bristol-Myers SquibbBMY · Health Care5.3$124.5B$60.93 3.19% down 34% up United States
14Oruka TherapeuticsORKA · Health Care5.4$6.6B$96.66 2.60% down 262% up United States
15ErascaERAS · Health Care5.6$5.1B$14.57 3.57% down 428% up United States
16Alnylam PharmaceuticalsALNY · Health Care5.8$21.1B$157.19 1.59% down 65% down United States
17Ligand PharmaceuticalsLGND · Health Care6.2$6B$299.42 0.76% down 46% up United States
18Vertex PharmaceuticalsVRTX · Health Care6.5$135.5B$534.47 0.62% down 23% up United States
19VeradermicsMANE · Health Care6.7$5.3B$126.39 1.30% down 239% up United States
20Praxis Precision MedicinesPRAX · Health Care6.8$8.6B$308.39 0.61% down 69% up United States
21Protagonist TherapeuticsPTGX · Health Care7.5$8.2B$125.30 0.38% up 48% up United States
22Merck & CoMRK · Health Care7.9$354.9B$143.98 0.33% down 50% up United States
23Belite BioBLTE · Health Care8.0$6.3B$157.15 3.33% down 32% up United States
24Johnson & JohnsonJNJ · Health Care8.3$675.4B$280.57 0.70% down 41% up United States
25Corcept TherapeuticsCORT · Health Care9.3$7.8B$71.13 2.75% up 8% down United States
26Spyre TherapeuticsSYRE · Health Care9.4$9B$94.95 4.45% down 312% up United States
27ZoetisZTS · Health Care10.3$34.1B$83.85 0.64% down 29% down United States
28Cogent BiosciencesCOGT · Health Care10.4$4.7B$26.98 1.68% down 18% down United States
29Ionis PharmaceuticalsIONS · Health Care11.4$4.5B$27.05 3.43% down 62% down United States
30Amneal PharmaceuticalsAMRX · Health Care13.8$7.3B$21.08 0.71% down 83% up United States
31TG TherapeuticsTGTX · Health Care15.4$9.5B$62.88 0.19% up 101% up United States
32Summit TherapeuticsSMMT · Health Care15.5$8.7B$10.94 7.49% down 30% down United States
33Madrigal PharmaceuticalsMDGL · Health Care15.8$9.9B$426.93 0.70% up 24% down United States
34Eli LillyLLY · Health Care31.3$1.26T$1,416.29 1.07% down 39% up United States
35InsmedINSM · Health Care36.2$26.3B$119.75 2.55% down 39% down United States
36Axsome TherapeuticsAXSM · Health Care68.2$7.2B$136.72 0.21% down 7% down United States
37Rhythm PharmaceuticalsRYTM · Health Care89.6$7.9B$113.72 5.80% up 7% up United States
38Arrowhead PharmaceuticalsARWR · Health Care122$6.1B$43.45 1.73% down 9% up United States
39Travere TherapeuticsTVTX · Health Care213$4.8B$50.28 1.17% up 38% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 22 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which pharmaceuticals have the lowest P/B ratio?

Viatris (1.7), BioMarin Pharmaceutical (1.8) and Pfizer (1.8) have the lowest P/B ratio of the 39 pharmaceuticals ranked here as of 17 Nov 2026, 17:20 UTC.

How many pharmaceuticals are in this ranking?

39 are ranked by P/B ratio. 22 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

Their combined market value is $5.17T as of 17 Nov 2026, 17:20 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Pharmaceuticals by P/B ratio”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.